Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Abstract No: 355 TO EVALUATE THE EFFICACY AND SAFETY OF TELITACICEPT AND STANDARD TREATMENT FOR 6MONTHS IN IGA NEPHROPATHY, SINGLE CENTER, RANDOMIZED, OPEN LABEL, COMPARATIVE STUDY. Local targets link to admitted publications; unresolved targets remain external evidence.
